Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.2177
+0.0157 (7.77%)
At close: May 23, 2025, 4:00 PM
0.2103
-0.0074 (-3.40%)
After-hours: May 23, 2025, 7:59 PM EDT
Incannex Healthcare Employees
Incannex Healthcare had 9 employees as of June 30, 2024. The number of employees increased by 6 or 200.00% compared to the previous year.
Employees
9
Change
6
Growth
200.00%
Revenue / Employee
$10,889
Profits / Employee
-$2,415,889
Market Cap
6.00M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
IXHL News
- 3 days ago - Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution - GlobeNewsWire
- 7 days ago - Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants - GlobeNewsWire
- 8 days ago - Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 9 days ago - Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On? - Benzinga
- 9 days ago - Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - GlobeNewsWire
- 7 weeks ago - Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - GlobeNewsWire
- 2 months ago - Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025 - Newsfile Corp